The proposed Histiocytic Disorders Workshop is an unprecedented gathering of physicians and scientists—across adult and pediatric diseases, HLH and histiocytic neoplasms—eager to align priorities and approaches to research in these diseases. The two-day event will include approximately 75 in-person attendees including histiocytosis scholars, patients and stakeholders, experts in patient engagement and patient-reported outcomes, diversity and inclusion, junior career development, and representatives from industry as well as from federal agencies.
Funding for this conference was made possible (in part) by (1 R13TR004891-01) from the National Center for Advancing Translational Sciences (NCATS). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.